TVGN
Tevogen Inc.
Key Financials
Operating Income
$-26140515
↑ 51.2%
Net Income
$-26275432
↓ 91.4%
EPS (Diluted)
$-8.08
↓ 11442.9%
Total Liabilities
$12.6M
↑ 24.5%
Total Assets
$4.4M
↑ 26.6%
Cash & Equivalents
$0.00
NaN%
Operating Cash Flow
$-12328577.00
↓ 2.7%
Shareholders' Equity
$-8234726.00
↓ 23.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/14/2026 | View on SEC |
| DEF 14A | 8/3/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| PRE 14A | 7/23/2026 | View on SEC |
| SCHEDULE 13D/A | 7/14/2026 | View on SEC |
| 4 | 7/10/2026 | View on SEC |
| 4 | 7/10/2026 | View on SEC |
| 4 | 7/10/2026 | View on SEC |
| 4 | 7/10/2026 | View on SEC |
| 4 | 7/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TVGN |
| Company Name | Tevogen Inc. |
| CIK | 1860871 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 646-807-8832 |